Page last updated: 2024-11-07

prednisone and Postpoliomyelitis Syndrome

prednisone has been researched along with Postpoliomyelitis Syndrome in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Postpoliomyelitis Syndrome: A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyer, FC1
Tiffreau, V1
Rapin, A1
Laffont, I1
Percebois-Macadré, L1
Supper, C1
Novella, JL1
Yelnik, AP1
Dinsmore, S1
Dambrosia, J1
Dalakas, MC1

Reviews

1 review available for prednisone and Postpoliomyelitis Syndrome

ArticleYear
Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy.
    Annals of physical and rehabilitation medicine, 2010, Volume: 53, Issue:1

    Topics: Cholinesterase Inhibitors; Glucocorticoids; Humans; Immunoglobulins; Postpoliomyelitis Syndrome; Pre

2010

Trials

1 trial available for prednisone and Postpoliomyelitis Syndrome

ArticleYear
A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome.
    Annals of the New York Academy of Sciences, 1995, May-25, Volume: 753

    Topics: Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Muscles; Postpoliomyelitis Syndrome

1995